Emisphere is testing the strategy to administer insulin to diabetics and to deliver the blood-thinning protein heparin to people undergoing hip-replacement surgery, who sometimes experience blood clots.
Emisphere is testing the strategy to administer insulin to diabetics and to deliver the blood-thinning protein heparin to people undergoing hip-replacement surgery, who sometimes experience blood clots.
艾米球科技公司正在测试这种投药方法，将胰岛素投药给糖尿病患，以及将防止血液凝固的肝素投给接受髋关节置换手术、可能会碰上血栓问题的病患。